Multidisciplinary Approach for Bone Metastasis: A Review
Overview
Authors
Affiliations
Progress in cancer treatment has improved the survival of patients with advanced-stage cancers. Consequently, the clinical courses of patients are prolonged and often accompanied by morbidity due to bone metastases. Skeletal-related events (SREs), such as pathological fractures and spinal paralysis, cause impairment in activities of daily life and quality of life (QOL). To avoid serious SREs causing impairment in QOL and survival, early diagnosis and a prophylactic approach are required. It is necessary to initiate a bone management program concurrently with the initiation of cancer treatment to prevent complications of bone metastasis. In addition, the requirement of a multidisciplinary approach through a cancer board focusing on the management of bone metastases and involving a team of specialists in oncology, palliative care, radiotherapy, orthopedics, nuclear medicine, radiology, and physiatrists has been emphasized. In the cancer board, a strong focus is placed on the prevention of complications due to bone metastases and on reductions in the high morbidity, hospitalization rate, and overall costs associated with advanced-stage cancers. Recent reports suggest the usefulness of such approaches. The multidisciplinary approach through a cancer board would improve QOL and prognosis of patients, leading to new or continued systemic therapy for primary cancers.
Standardization of a Model of Vertebral Metastasis of Breast Cancer in CD1/Nu/Nu Mice.
Reyes Soto G, Miranda-Galvan V, Uribe-Uribe N, Escobar-Valderrama J, Alanis-Mendizabal J, Medina-Velazquez L Cureus. 2025; 17(1):e77291.
PMID: 39931605 PMC: 11809943. DOI: 10.7759/cureus.77291.
Ghanta P, Hessel E, Arias-Alvarado A, Aghayev M, Ilchenko S, Kasumov T Sci Rep. 2024; 14(1):27201.
PMID: 39516568 PMC: 11549321. DOI: 10.1038/s41598-024-79006-w.
Segi N, Nakashima H, Ito S, Ouchida J, Shiratani Y, Shimizu T Global Spine J. 2024; :21925682241297948.
PMID: 39484810 PMC: 11559722. DOI: 10.1177/21925682241297948.
Manzino A, Wilson C Front Rehabil Sci. 2024; 5:1384782.
PMID: 39363992 PMC: 11446967. DOI: 10.3389/fresc.2024.1384782.
Kashima R, Yoshikawa R, Saho W, Nakamura K, Tsuda Y, Harada R Prog Rehabil Med. 2024; 9:20240032.
PMID: 39359879 PMC: 11443026. DOI: 10.2490/prm.20240032.